People: Evolus Inc (EOLS.OQ)
12.20USD
9 Dec 2019
-- (--)
$12.20
--
--
--
--
125,824
$30.25
$10.29
Sabad, Alejandro
Mr. Alejandro Sabad is Vice President - Operations of the Company. Mr. Sabad brings over 25 years of combined industry & consulting experience with a range of life science companies and is recognized for his expertise in global manufacturing and operations. Mr. Sabad formerly served as a Managing Director at Deloitte Consulting where he served as the Technical Operations Solution and Global Manufacturing Strategy & Operations Lead and led the Contract Development and Manufacturing Organizations (CDMO) segment for the practice. Prior to Deloitte, he served as Vice President of Operations Strategy and Network Performance Management at MedImmune, AstraZeneca's global biologics division which contributed over $1.0 billion of annual revenue. Mr. Sabad received an MBA in Strategy & Finance from the Mendoza School of Business at the University of Notre Dame and a BA from the University of California, Los Angeles.
Basic Compensation
| Total Annual Compensation, | -- |
| Restricted Stock Award, | -- |
| Long-Term Incentive Plans, | -- |
| All Other, | -- |
| Fiscal Year Total, | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Exercisable | -- | -- |
| Unexercisable | -- | -- |
| Exercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Vikram Malik |
158,901 |
David Moatazedi |
5,794,180 |
Lauren Silvernail |
3,656,890 |
Michael Jafar |
3,929,160 |
Alejandro Sabad |
-- |
Kurt Knab |
-- |